This content is from: Portfolio Activist Campaigns Fall, but Poison Pill Adoption Surges Shareholder activists launched fewer campaigns in the first quarter than they have in some time, but companies are bracing themselves for that to change. By Amanda Cantrell April 29, 2020
This content is from: Premium This Company May Be JANA’s Next Activist Target Why investors are focusing on a company best known for making caskets. By Stephen Taub May 27, 2020
This content is from: Premium Icahn’s Investment Portfolio Extends Losses The activist investor is losing money from both his long and short books. By Stephen Taub November 09, 2020
This content is from: Portfolio Activist Pressure on GAM Heats Up Investment firms Krupa Global Investments and Bluebell Capital Partners want to see a turnaround at GAM or will aim to replace the firm's board in 2020. By Alicia McElhaney December 11, 2019
This content is from: Premium Carl Icahn is This Year’s Top Activist The veteran investor is leading U.S. campaigns in a year when global activism is in a slump. By Michelle Celarier July 09, 2019
This content is from: Culture Why the SEC May Have Scrapped Its Controversial 13F Proposal The proposed rule change drew sharp criticism — but it also rested on shaky legal grounds. By Alicia McElhaney October 30, 2020
